We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
24 hedge funds and large institutions have $62.2M invested in ZyVersa Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
14% more funds holding
Funds holding: 21 → 24 (+3)
12% more capital invested
Capital invested by funds: $55.4M → $62.2M (+$6.75M)
0.02% more ownership
Funds ownership: 0.2% → 0.22% (+0.02%)
Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
5
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$2.79M |
| 2 |
D.E. Shaw & Co
New York
|
+$2.32M |
| 3 |
Barclays
London,
United Kingdom
|
+$1.38M |
| 4 |
SCM
Saba Capital Management
New York
|
+$1.09M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$521K |
Top Sellers
| 1 |
MSU
Mizuho Securities USA
New York
|
-$1.83M |
| 2 |
FLC
Fifth Lane Capital
Austin,
Texas
|
-$496K |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
-$62.6K |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$20.9K |
| 5 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$6.95K |
